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Abstract
Plasmodium falciparum is a highly lethal malaria parasite of humans. A major portion of its life cycle is dedicated to invading
and multiplying inside erythrocytes. The molecular mechanisms of erythrocyte invasion are incompletely understood. P.
falciparum depends heavily on sialic acid present on glycophorins to invade erythrocytes. However, a significant proportion
of laboratory and field isolates are also able to invade erythrocytes in a sialic acid-independent manner. The identity of the
erythrocyte sialic acid-independent receptor has been a mystery for decades. We report here that the complement receptor
1 (CR1) is a sialic acid-independent receptor for the invasion of erythrocytes by P. falciparum. We show that soluble CR1
(sCR1) as well as polyclonal and monoclonal antibodies against CR1 inhibit sialic acid-independent invasion in a variety of
laboratory strains and wild isolates, and that merozoites interact directly with CR1 on the erythrocyte surface and with sCR1-
coated microspheres. Also, the invasion of neuraminidase-treated erythrocytes correlates with the level of CR1 expression.
Finally, both sialic acid-independent and dependent strains invade CR1 transgenic mouse erythrocytes preferentially over
wild-type erythrocytes but invasion by the latter is more sensitive to neuraminidase. These results suggest that both sialic
acid-dependent and independent strains interact with CR1 in the normal red cell during the invasion process. However, only
sialic acid-independent strains can do so without the presence of glycophorin sialic acid. Our results close a longstanding
and important gap in the understanding of the mechanism of erythrocyte invasion by P. falciparum that will eventually
make possible the development of an effective blood stage vaccine.
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Introduction
The erythrocyte invasion mechanisms of P. falciparum are varied
and complex. Erythrocytes are rich in surface glycophorins which
contain sialic acid. Earlier studies demonstrated that invasion of
erythrocytes could be inhibited by treatment of erythrocytes with
neuraminidase, which removes sialic acid, or blocked by purified
glycophorin A [1–3]. In addition, erythrocytes genetically deficient
in glycophorin A [En(a-)], glycophorin B (S-s-U-), or sialic acid
(Tn) showed reduced invasion compared to normal cells [1,4].
These studies suggested that sialic acid and the peptide backbones
of glycophorin A and B play a role in the invasion of erythrocytes
by P. falciparum. Glycophorin C was later added to this list [5].
However, some malaria strains exhibit sialic acid-independent
invasion [6–8], which is not affected by the absence of glycophorin
A or B [6] or by antibodies against glycophorin A [7], but it is
trypsin sensitive [6,9,10]. The putative sialic acid-independent
trypsin-sensitive receptor on erythrocytes has been referred to as
‘‘X’’ [9]. The relevance of the sialic acid-independent pathway has
been shown by the demonstration that many field isolates can
utilize this invasion pathway [11,12]. Therefore, the identification
of the host and parasite molecules involved in this pathway is a
necessary step towards the ultimate goal of developing a malaria
vaccine that effectively blocks erythrocyte invasion.
We considered CR1 to be a good candidate for being ‘‘X’’
because, like ‘‘X’’, CR1 is known to be highly sensitive to trypsin
PLoS Pathogens | www.plospathogens.org 1 June 2010 | Volume 6 | Issue 6 | e1000968and does not contain sialic acid [13]. In addition, CR1 is used by
several pathogens as a receptor for entry into host cells [14,15].
Structurally, it is a 200 kD integral membrane protein found on all
erythrocytes and most leukocytes and it is composed of 30
complement control protein (CCP) modules which can be
organized, based on their degree of homology, into long
homologous repeats (LHR) A–D [16]. It also serves as a co-factor
to Factor I for the inactivation of C3b and accelerates the decay of
C3 and C5 convertases and thus protects cells from autologous
complement attack [17]. CR1 also mediates the binding of mature
infected erythrocytes (schizonts) to uninfected erythrocytes (roset-
ting) [18].
Results
Antibodies to CR1 and Soluble CR1 (sCR1) Block Sialic
Acid-independent Invasion
In order to test the hypothesis that CR1 is the sialic acid-
independent receptor on erythrocytes we used the P. falciparum
sialic acid-independent laboratory strain 7G8 [6]. We initially used
a chicken polyclonal anti-human CR1 that recognizes CR1 on red
cells specifically as measured by flow cytometry (Figure 1A and 1B)
and is capable of immunoprecipitating CR1 from a red cell lysate
(Figure 1C). Incubation of neuraminidase-treated erythrocytes
with either sCR1 [19] or anti-human CR1 Fab blocked 7G8
invasion of neuraminidase-treated erythrocytes in a dose-depen-
dent manner (Figure 2A–D) but had no discernible effect on the
invasion of untreated erythrocytes. In order to determine whether
we were working at excess concentrations of antibodies and sCR1
we measured the invasion inhibition by anti-CR1 antibody and
sCR1 under increasing starting parasitemia. We observed stable
inhibition of invasion within a wide range of starting parasitemias
(Figure S1).
Next, to further test the specificity of our findings and narrow
down the binding site within CR1 we used a panel of monoclonal
antibodies directed against various CR1-defined CCPs: J3D3,
E11, To5, and J3B11. J3B11 and J3D3 were the most effective in
blocking invasion (Figure 2E). These monoclonal antibodies are
known to bind to adjacent CCPs within the C3b binding sites and
the CR1 binding site may overlap these two epitopes [20]. J3B11
also interferes with the binding of PfEMP-1 [21], the putative
malaria ligand that mediates rosetting and cytoadherence of
schizonts to endothelial cells [18,22]. Although published data
suggest that J3D3 and To5 bind within the same group of CCPs
[20], the fact that To5 showed minimal, if any, inhibition suggests
that finer epitope mapping of this antibody may demonstrate that
its epitope is distinct from J3D3. E11 recognizes CCPs that also
contain the epitopes for J3D3 and J3B11 but its epitope seems to
be more conformationally dependent [20]. To further confirm our
results and to look for synergy between J3B11 and J3D3 we
repeated these studies using these monoclonals singly or in
combination (Figure 3). The results showed that at 1 mg/ml there
was some synergistic effect resulting from the combination of
antibodies. However, at concentrations of 5 mg/ml or higher
J3B11 was more effective than J3D3 and there was no synergy.
Therefore, J3B11 appears to be s binding closest to the ligand
binding site in CR1.
CR1 Is a Sialic Acid-independent Receptor for Several
Laboratory Strains and Wild Isolates of P. falciparum
In an effort to test whether our results represent a general
phenomenon, we examined several additional P. falciparum sialic
acid-independent laboratory strains (HB3, 3D7, and Dd2NM)
[8,9]. In two of the three laboratory strains (HB3 and 3D7) anti-
CR1 Fab or sCR1 resulted in a reduction of invasion of untreated
erythrocytes that was statistically significant (Figure 4). Interest-
ingly, the irrelevant anti-CD55 monoclonal antibody 4D3 reduced
invasion of untreated erythrocytes by HB3 but had no effect on the
other strains. In contrast to untreated erythrocytes, invasion of
neuraminidase-treated cells was consistently reduced in all strains
by the use of polyclonal or monoclonal antibodies against CR1 as
well as by sCR1. Monoclonal and polyclonal antibodies were least
effective in blocking HB3 invasion and most effective in blocking
3D7 invasion. sCR1 was usually more effective than antibodies in
reducing the sialic acid-independent invasion of red cells (.90%
for HB3 and 3D7, and 74% for Dd2NM). Chicken IgY Fab
control had a paradoxical effect by increasing the invasion of HB3.
Altogether, these results suggest that the use of CR1 as an
erythrocyte receptor is common in sialic acid-independent strains,
but strains such as HB3 and Dd2NM may utilize additional sialic
acid-independent receptors.
In addition to the laboratory strains mentioned above, we
examined the role of CR1 in the invasion of red cells in three
sialic acid-independent wild strains from Kenya (Table S1). Like
the laboratory strains tested, the invasion of neuraminidase-
treated red cells was inhibited by sCR1 and chicken anti-CR1.
However, unlike laboratory strains, we observed modest but
significant inhibition of invasion of intact red cells especially with
sCR1.
Merozoites Interact with Red Cell CR1 and with sCR1-
coated Microspheres
To demonstrate direct interaction between merozoites and
CR1, we performed immunofluorescent microscopy using freshly
released merozoites. In agreement with previous observations [23],
CR1 appeared as a punctate or speckled pattern on red cells which
disappeared upon trypsinization (Figure S2). Merozoites were
observed interacting directly with CR1 on erythrocytes both in
neuraminidase-treated and untreated control cells (Figure 5,
Figure S3, and Supplementary 3D Videos S1, S2, S3, S4, S5,
and S6). Although not all merozoites were seen to interact directly
with CR1, examples of this interaction were easy to find. When
interaction was observed, CR1 staining always appeared to be
Author Summary
Plasmodium falciparum malaria is a blood parasite that
lives for the most part inside red cells. It is responsible for
the death of 1-2 million people every year. The mecha-
nisms by which the parasite invades red cells are complex
and not completely understood. For many years it has
been known that proteins called glycophorins are used by
the parasite to gain entry into the red cell. However, the
existence of another protein that allows entry independent
of glycophorins has been suspected for nearly as long. The
identity of the alternative protein has been a mystery
difficult to solve. In this article we present strong evidence
that the alternative protein is the complement receptor 1.
The complement receptor 1 is a well-studied protein that
is known to be important in protecting red cells from
attack by the host immune system as well as suspected of
having other roles in the development of malaria
complications. The recognition of the additional role of
complement receptor 1 in red cell invasion will allow the
definitive identification of malaria proteins that interact
with it and that could be used in a future vaccine cocktail
to block red cell invasion.
CR1 Is a Malaria Sialic Acid-Independent Receptor
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be occurring. In addition, while the interaction often appeared to
be focal, in some instances merozoites seemed to be partially or
completely coated by CR1 (Figure S3B and S3D). We observed no
clearly discernible difference between 7G8 and the sialic acid-
dependent strain Dd2 by immunofluorescent microscopy (data not
shown), suggesting that both strains can interact with CR1 or that
this technique lacks sensitivity to detect differences in the way the
two strains interact with CR1. To further document the
interaction of merozoites with CR1, we incubated enriched
schizonts and late trophozoites with polystyrene microspheres
coated with sCR1, BSA, glycophorin A, or fetuin. Figure 6 shows
that merozoites bind to CR1-coated microspheres with greater
frequency than to microspheres coated with BSA, glycophorin A,
or fetuin. Further, the binding to sCR1-coated microspheres was
inhibited by chicken anti-CR1 whereas the binding to BSA-coated
microspheres was not inhibited by polyclonal rabbit anti-BSA.
CR1 Levels Correlate with the Degree of Erythrocyte
Invasion
Based on our findings, we predicted a correlation between CR1
expression level and the level of P. falciparum invasion, especially in
neuraminidase-treated cells. In lieu of the absence of individuals
with complete CR1 deficiency, we took advantage of the fact that
CR1 is known to have two quantitative alleles (H and L) that are
co-dominant and result in the distribution of CR1 levels into low
(LL), medium (HL), and high (HH) expressors [16]. We used flow
cytometry to determine the CR1 median fluorescence intensity
(MFI) of 75 healthy individuals. Erythrocytes of 27 individuals,
spanning the range of low, medium, and high expressors, were
used for invasion assays. A positive correlation was found between
CR1 MFI and invasion for both intact and neuraminidase-treated
red cells. Furthermore, this relationship was much stronger in
neuraminidase-treated cells than in untreated cells (Figure 7),
which is consistent with a greater role of CR1 as a receptor in the
absence of sialic acid.
P. falciparum Invades CR1 Transgenic Mouse Red Cells
Preferentially Over Wild-type Red Cells
Finally, we compared the P. falciparum invasion of human CR1
transgenic mouse erythrocytes [23] to wild-type mouse erythro-
cytes. In the mouse, CR1 is expressed mostly on B cells and not on
red cells [24]. Although mouse glycophorins contain sialic acid, P.
falciparum invades mouse erythrocytes at a lower rate than human
erythrocytes [25] probably due to structural differences between
human and mouse glycophorins [26]. P. falciparum 7G8 invaded
CR1 transgenic mouse erythrocytes preferentially over wild-type
erythrocytes (Figure 8). Anti-CR1 monoclonal J3B11 and
polyclonal anti-CR1 Fab reduced the invasion of transgenic
erythrocytes by 7G8 down to wild-type levels (Figure 8B). While
the sialic acid-dependent strain Dd2 also showed increased
invasion of CR1 transgenic mouse erythrocytes, following
neuraminidase treatment the invasion decreased dramatically
compared to that of 7G8 (Figure 8C). These experiments suggest
that both sialic acid-independent and dependent strains are able to
interact with CR1, but for the latter CR1-mediated invasion may
rely on the presence of intact sialic acid on glycophorin.
Invasion of Neuraminidase-treated Red Cells by Sialic
Acid-dependent Strains Is Less Sensitive to Inhibition by
Anti-CR1 and sCR1
To further explore the interaction of sialic acid-dependent
strains with CR1, we compared the ability of anti-CR1 and sCR1
to inhibit the invasion of neuraminidase-treated red cells in sialic
acid-dependent strains Dd2 and FVO and sialic acid-independent
strains 7G8 and 3D7 (Figure 9). While anti-CR1 and sCR1
inhibited 75–90% of invasion in 3D7 and 7G8, the magnitudes of
inhibition in Dd2 and FVO were only 30–50%. Therefore, the
Figure 1. Chicken anti-human CR1 recognizes red cell CR1. (A) Binding of chicken anti-human CR1 Fab is abolished by treatment of
erythrocytes with trypsin but not with neuraminidase. (B) Binding of chicken anti-CR1 Fab to human red cells is abolished by incubation with soluble
CR1 (sCR1) but not by bovine serum albumin. (C) PAGE of chicken anti-CR1 immunoprecipitates, sCR1 and red cell lysates run on Novex Nupage Bis-
tris 4–12% acrylamide gel under reducing conditions and stained with silver. Lane 1: Immunoprecipitate with chicken anti-CR1 from intact red cell
lysate. Lane 2: Immunoprecipitate with chicken anti-CR1 from trypsin-treated red cell lysate. Lane 3: Immunoprecipitate with control chicken IgY from
intact red cell lysate. Lane 4: Immunoprecipitate with chicken IgY from trypsin-treated red cell lysate. Lane 5: 0.01 mg of purified sCR1. Lane 6: 1 mlo f
intact red cell lysate used for immunoprecipitation. Lane 7: 1 ml of trypsin-treated red cell lysate used for immunoprecipitation.
doi:10.1371/journal.ppat.1000968.g001
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PLoS Pathogens | www.plospathogens.org 3 June 2010 | Volume 6 | Issue 6 | e1000968Figure 2. Inhibition of P. falciparum 7G8 invasion by sCR1 and antibodies against CR1. (A) sCR1 blocked invasion of neuraminidase-treated
erythrocytes in a dose-dependent manner while bovine serum albumin (BSA) and a-2-macroglobulin had no effect. (B) No protein had an effect on
the invasion of untreated erythrocytes. (C) Chicken anti-human CR1 Fab blocked invasion of neuraminidase-treated erythrocytes in a dose-dependent
manner while purified chicken IgY Fab control had no effect. (D) No antibody had effect on the inhibition of intact red cells. (C–D) The concentration
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dependent strains, although minimal, is much less sensitive to
inhibition by anti-CR1 and sCR1.
Discussion
We have shown in a logical and systematic manner that CR1 is
a sialic acid-independent receptor for P. falciparum. This molecule
was previously dismissed when the invasion of erythrocytes
expressing very low levels of CR1 (Helgeson phenotype) by sialic
acid-independent strain Dd2SNM (similar to Dd2NM used here)
was not completely abolished after neuraminidase treatment [27].
These results may be explained by the efficiency of very low levels
of CR1 in promoting sialic acid-independent invasion and/or by
the presence of an alternative receptor used by Dd2NM (Figure 2).
Using the prototypical sialic acid-independent strain 7G8, we
demonstrated that sCR1 as well as polyclonal and monoclonal
antibodies directed against CR1 drastically reduced or eliminated
sialic acid-independent invasion while control proteins and
antibodies did not. Similar results were obtained with the sialic
acid-independent laboratory strains 3D7, HB3, and Dd2NM.
However, for HB3 and Dd2NM CR1 did not appear to be the
only sialic acid-independent receptor since these strains showed
some residual invasion of neuraminidase-treated red cells in the
presence anti-CR1 antibodies and sCR1. In addition, we have
shown that the sialic acid-independent invasion of three field
isolates from Kenya can also be inhibited by these reagents.
In two of the four laboratory strains tested here we were able to
show significant inhibition of intact erythrocytes with anti-CR1
Fab and/or sCR1 ranging from 20–30% and similar results were
obtained using wild isolates from Kenya. Although sCR1 is
present in serum, its levels are much lower than those required for
inhibition of merozoite invasion [28]. These findings suggest that
for many malaria strains CR1 is an alternative receptor to
glycophorins on intact red cells. The partial inhibition of invasion
of intact red cells by anti-CR1 and sCR1 is not surprising given
that there are in the order of 10
6 molecules of glycophorin A per
erythrocyte [29] compared to an average of 600 of CR1. The
correlation between invasion and CR1 expression level further
suggests that the contribution of CR1 to the overall invasion is
determined by the number of CR1 molecules present on the red
cell. In addition, invasion pathways may work in a hierarchical
Figure 3. Effect of combined monoclonals on sialic acid-independent invasion of 7G8. Monoclonals J3B11 and J3D3 were used singly or in
combination. When used in combination, each monoclonal was used at half of the total concentration. 4D3 is a negative control antibody that
recognizes red cell CD55. P values are for the comparison to the no-inhibitor control using Dunnett’s pairwise multiple comparison t-test using
matching by experiment date. Parasitemia was determined using flow cytometry. The figure represents a summary of 3 experiments. Bars are means 6
standard deviations.
doi:10.1371/journal.ppat.1000968.g003
of antibody stocks was 80 mg/ml. Summary of three experiments. (E) Inhibition of P. falciparum 7G8 invasion using anti-CR1 monoclonal antibodies.
Numbers above bars are P values for the comparison with the no antibody (No Ab) control using Dunnett’s pairwise multiple comparison t-test,
taking into account matching by experiment date. An IgG1 irrelevant monoclonal (R&D Systems, Minneapolis, MN, USA) and anti-CD55 monoclonal
(clone NaM16-4D3) (4D3) (Santa Cruz Biotechnology, Inc.) were used as negative controls. E11, To5, J3D3, and J3B11 are anti-CR1 monoclonal
antibodies. All monoclonal antibodies were used at 1 mg/ml except in two experiments where every monoclonal was used at 15 mg/ml. Bars
represent means 6 standard deviations. Invasion rates in untreated controls (no antibody) ranged from 2% to 14%.
doi:10.1371/journal.ppat.1000968.g002
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prominent in the face of silencing of more dominant ones [30].
Since there is no complete absence of CR1 among humans, to
show the effect of complete absence of CR1 on invasion we
compared the invasion of wild-type mouse red cells, which do not
express CR1, and mouse transgenic red cells expressing human
CR1. Using this system we showed that expression of CR1
rendered red cells more susceptible to P. falciparum invasion.
Interestingly, both sialic acid-independent and dependent strains
showed increased invasion of CR1 transgenic mouse red cells but
the latter seemed to require the intact sialic acid of glycophorin for
optimal CR1-mediated invasion. This is also supported by the
finding that invasion of neuraminidase-treated red cells by sialic
acid-dependent strains is less sensitive to inhibition by anti-CR1
and sCR1 (Figure 9). One possible explanation for these
observations is that the CR1 ligand in sialic acid-dependent
strains may require interaction with both CR1 and glycophorin to
mediate invasion optimally. The involvement of merozoite ligands
in both sialic-dependent and independent invasion has been
postulated [31] and our findings are consistent with this concept.
The ability of merozoites to interact with CR1 was shown by
immunofluorescence microscopy and without question by the
demonstration that merozoites can bind preferentially to sCR1-
coated polystyrene microspheres (Figure 6). That this interaction is
mediated by a receptor-ligand interaction was demonstrated by
the inhibition induced by chicken anti-CR1. By contrast, the
interaction of merozoites with BSA-coated microspheres was not
inhibited by rabbit anti-BSA. Surprisingly, binding to glycophorin
A-coated microspheres was relatively poor, suggesting that
glycophorin may be less effective than CR1 in mediating
merozoite attachment. Regardless, these results confirm that
merozoites can interact directly with CR1.
P. falciparum has at its disposal an extensive array of ligands
each of which is involved in one or more invasion pathways
defined mostly by enzymatic treatment of erythrocytes. The
ligands so far identified belong to two major families of proteins:
the erythrocyte-binding like (EBL) family [8], which contains
EBA-175 [32], and the recently identified reticulocyte-binding
like (RBL) family of proteins: PfRh1, PfRh2a, PfRh2b, PfRh3,
and PfRh4 [33]. Two studies have reported that the expression of
PfRh4 correlates with sialic acid-independent invasion [34,35].
Antibodies against this protein blocked sialic acid-independent
invasion in one study [36] but not in other [37]. In addition,
parasite knockouts of PfRh2a and PfRh2b show decreased sialic
acid-independent invasion suggesting that these molecules may
also be involved in this pathway [31]. Additional work will be
needed to determine whether CR1 serves as receptor for any of
the PfRh ligands.
There are several scenarios under which the CR1-mediated
invasion pathway could become more prominent. One scenario
may occur when the parasite encounters red cell or glycophorin
variants that lack the receptors for the dominant pathway. This
may explain why the CR1-mediated pathway plays such a major
role in the invasion of CR1-transgenic mouse red cells. A second
situation may involve the development of a natural immune
response by the host against the dominant pathway which may
drive switching to a less dominant pathway or selection of
parasites that use alternative pathways. Already some evidence
from the field suggests that this mechanism may actually be at
play in endemic populations [38]. Thirdly, and most importantly,
immunologic pressure induced by vaccination against the
dominant ligands involved in the glycophorin-dependent path-
way but not against the CR1-mediated pathway may lead to
selection of strains that are more reliant on the latter [39].
Figure 4. Inhibition of invasion of P. falciparum strains HB3, 3D7, and Dd2NM. HB3 invasion of neuraminidase-treated cells was least
affected by monoclonal and polyclonal antibodies against CR1. Monoclonal antibodies were used at 4 mg/ml. Fab fragments were used at 8 mg/ml
and purified proteins were used at 50 mg/ml. Numbers above bars are P values for the comparison with the no-inhibitor control using Dunnett’s
pairwise multiple comparison t test, taking into account matching by experiment date. Bars represent means 6 standard deviations. Alpha-2-mac=
a-2-macroglobulin. Invasion rates for untreated erythrocytes with no inhibitor ranged from 3% to 37%.
doi:10.1371/journal.ppat.1000968.g004
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invasion pathways be represented in a future malaria blood stage
vaccine. The demonstration that CR1 is a sialic acid-independent
receptor of P. falciparum will facilitate the identification of its
ligand(s) and the development of a vaccine that effectively blocks
red cell invasion.
Materials and Methods
Parasites and Parasite Culture
Strains HB3 and 7G8 were obtained from the Malaria Research
and Reference Reagent Resource Center (ATCC, Manasas, VA,
USA). Strain 3D7 Oxford was provided by the Walter Reed Army
Institute of Research (WRAIR) through the generosity of David
Haynes. Dd2NM was derived as described from a Dd2 stock at the
WRAIR. Wild strains were obtained from malaria-infected
children in western Kenya under approved protocols. Parasite
cultures were maintained and synchronized in O+ blood with 10%
heat inactivated serum using temperature cycling.
Enzymatic Treatment of Erythrocytes
Neuraminidase treatment was as described except that eryth-
rocytes at 50% hematocrit in RPMI 1640 were incubated in
250 mU/ml of Vibrio cholera neuraminidase (Sigma-Aldrich, St.
Louis, MO, USA). For human red cells, the effectiveness of
digestion was verified by loss of binding of mouse anti-human
glycophorin A/B clone E3 (Sigma-Aldrich) used at a dilution of
1:3375 with a secondary FITC-conjugated anti-mouse IgG
(Sigma-Aldrich) at a dilution of 1:50.
Antibodies
Polyclonal chicken anti-CR1 (Accurate Chemical & Scientific
Corp., Westbury, NY, USA) and purified chicken IgY (Biomeda,
Foster City, CA, USA) were digested with the use of a commercial
kit (Thermo Fisher Sicentific, Rockford, IL, USA) to obtain Fab
fragments. The final stocks of Fab antibody were adjusted to a
concentration of 80 mg/ml. The following IgG1 monoclonal
antibodies directed against CR1 were also used: J3D3 (Biomeda
Corp., Foster City, CA, USA), To5 and E11 (Accurate), and
J3B11 (a generous gift of Dr. Jacques Cohen, Hospital Robert
Debre ´, Reims, France). An IgG1 irrelevant monoclonal (R&D
Systems, Minneapolis, MN, USA) and anti-CD55 monoclonal
(clone NaM16-4D3, IgG1) (Santa Cruz Biotechnology Inc., Santa
Cruz, CA, USA) were used as additional negative controls for
human erythrocytes. For experiments with mouse erythrocytes, we
used as negative control an IgG2a rat monoclonal antibody
directed against the complement receptor 1 related protein Y
(Crry) (Becton-Dickinson, San Jose ´, CA, USA) found on the
surface of mouse erythrocytes.
CR1 Immunoprecipitation
Human blood was obtained in citrate phosphate dextrose
(Sigma-Aldrich) and washed with RPMI to remove the buffy coat.
100 ml of packed red cells was incubated in 1 ml of RPMI 1640
with 500 mg/ml TPCK-treated trypsin (Sigma-Aldrich) for one
hour at 37uC and washed 63 with RPMI by centrifuging at
2,000 rpm for 5 min. Following the last wash, the pellet was
resuspended in 1 ml of double deionised water containing protease
Figure 5. Representative examples of interaction between merozoites and CR1 on neuraminidase-treated and untreated control
erythrocytes. CR1 showsa characteristic speckledpattern with aggregationaround themerozoite.Allnegative control antibodies showednostaining.
CR1 and glycophorin A were stained with specific antibodies followed by fluorochrome-conjugated secondary antibodies against glycophorin (red) and
CR1 (green). Merozoites (blue) were stained with the nucleic acid specific stain (Hoechst 33342). DIC=differential interference contrast.
doi:10.1371/journal.ppat.1000968.g005
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30 min. The ghosts were recovered by centrifugation at
10,000 rpm for 10 min and the pellet was washed twice more
with deionised water. Finally, the pellet was solubilized with 200 ml
of IP lysis buffer (Thermo Fisher Scientific) containing protease
inhibitor cocktail (Sigma-Aldrich) and allowed to sit in ice for
30 min after which it was stored at 220uC until used. An
additional 100 ml of packed red cells was similarly lysed and
solubilized without prior enzyme treatment. Aproximately 100 mg
of polyclonal chicken anti-CR1 or chicken IgY were covalently
linked to each of two 100 ml volumes of AminoLink Plus Coupling
Resin (50% slurry) following the manufacturer’s instructions
(Thermo Fisher Scientific). 500 ml of IP lysis buffer containing
5 ml of lysate from trypsin-treated or untreated red cells in the
presence of protease inhibitor cocktail was added to each chicken
anti-CR1 and IgY-linked resin pellets followed by incubation at
room temperature for two hours with constant mixing and
overnight at 4uC. The following day, the resins were washed
exhaustively with IP lysis buffer and the trapped proteins were
eluted with 50 ml low pH elution buffer followed by neutralization
with 5 ml of 2 M Tris. 10 ml of each eluate was loaded onto
separate lanes of a 4–12% Nupage-Novex Bis-Tris denaturing gel
(Invitrogen Corp., Carlsbad, CA, USA) followed by silver staining
(Thermo Fisher Scientific).
Invasion Assays
Schizont-infected erythrocytes were separated from uninfected
erythrocytes by magnet-activated cell sorting (MACS; Miltenyi
BioTec, Bergisch Gladbach, Germany) using ‘‘LS’’ columns. The
magnetized columns were equilibrated with 3 ml of RPMI
1640+0.2% sodium bicarbonate (elution buffer). Typically, a
24 ml culture was processed in three 8 ml aliquots. After loading
each 8 ml of culture onto the magnetized column, it was washed
and the infected erythrocytes eluted after demagnetization with
3 ml of elution buffer each time. The total infected erythrocytes
eluted were pelleted and resuspended in complete medium (RPMI
1640, 10% O+ plasma, 0.2% NaHCO3, 25 mM Hepes). O+
human erythrocytes, wild-type C57BL/6 mouse erythrocytes, or
Figure 6. 7G8 merozoites bind preferentially to sCR1-coated microspheres. (A) Protein-coated microspheres were incubated overnight
with purified late trophozoites and schizonts. Binding was detected by % of spheres positive for Hoechst staining using flow cytometry. Bars
represent means 6 standard deviations. The figure represents a summary of 2–3 experiments except for the rabbit anti-BSA which was included in
one experiment. (B) Fluorescence image of sCR1-coated microspheres showing attached merozoites (blue) and surface sCR1 (green). (C) Differential
interference contrast image of microspheres in B.
doi:10.1371/journal.ppat.1000968.g006
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PLoS Pathogens | www.plospathogens.org 8 June 2010 | Volume 6 | Issue 6 | e1000968Figure 7. Correlation between CR1 median fluorescence intensity (MFI) and invasion of erythrocytes by P. falciparum 7G8.
Erythrocytes from 27 healthy donors were used. To control for day-to-day variation the percent invasion as well as the CR1 MFI were normalized to an
erythrocyte standard sample that was used in every experiment. The CR1 MFI was re-measured once in 4 samples with extreme values. In 19 donors
the invasion assay was repeated 1–3 times. When more than one measurement was done, the mean was used for normalization.
doi:10.1371/journal.ppat.1000968.g007
Figure 8. Invasion of wild-type and human CR1 transgenic mouse erythrocytes by P. falciparum. (A) 7G8 invaded CR1 transgenic mouse
erythrocytes preferentially in a mixed culture of wild-type and CR1 transgenic mouse erythrocytes incubated overnight with or without schizonts and
analysed by flow cytometry. Upper panels show dot plots of Hoechst negative (uninfected) and positive (infected) erythrocytes. Numbers in
parenthesis represent the percent parasitemia (%P). Numbers without parenthesis in each quadrant represent the percent cells from the total
population. The lower panels show CR1 fluorescence histograms and the demarcation between CR1 positive (rectangle) and negative erythrocytes.
(B) Effect of polyclonal and monoclonal antibodies on the invasion of wild-type and CR1 transgenic mouse erythrocytes by 7G8. Only significant P
values are shown. *P is for the comparison between wild-type and CR1 transgenic red cells with no antibody. #P is for the comparison between
antibody and no antibody. Invasion in wild-type erythrocytes ranged from 0.2% to 4.5%. (C) Comparison of invasion of wild-type and CR1 transgenic
mouse erythrocytes between 7G8 and Dd2. Numbers above bars represent P values for the comparison to the wild-type untreated control. Invasion
was measured by flow cytometry and ranged from 0.45% to 5.5% in wild-type untreated erythrocytes. All bars represent means 6 standard
deviations.
doi:10.1371/journal.ppat.1000968.g008
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were plated in duplicate wells of a 96-well plate at a hematocrit of
2–4% in complete medium and were inoculated with schizont-
infected erythrocytes to achieve a parasitemia of 0.3 to 5% for
human red cells and 4–7% for mouse red cells. Plasma inactivated
by heating at 56uC for 45 min was used in most experiments
although we have not observed a difference in invasion or invasion
inhibition between heat-inactivated and non-inactivated plasma
(data not shown). For microscopic readout human red cell
invasion, only experiments in which the control untreated
erythrocytes gave 2% or higher parasitemia were included in the
analysis. Because much lower invasion rates were seen with mouse
red cells, all levels of parasitemias were accepted. Blocking
antibodies were added to uninfected erythrocytes prior to the
addition of schizont-infected erythrocytes. For blocking with
soluble CR1 (sCR1) (AVANT Immunotherapeutics, Inc., Need-
ham, MA, USA), bovine serum albumin, fetuin, and a-2-
macroglobulin (Sigma-Aldrich) were used as negative control
proteins depending on their availability. After a 16–22-hour
incubation the ring stage parasites in 1,000 erythrocytes were
counted in thin smears stained with Giemsa. The microscopist was
always blinded to the experimental group designation of each
slide. In some experiments, parasitemia was measured by flow
cytometry (see below). When comparing invasion across different
donors, the parasitemia was normalized to the parasitemia of a
single erythrocyte donor used as control in each assay using the
Figure 9. Inhibition of invasion of neuraminidase-treated red cells by sialic acid-dependent and independent strains. Bars represent
means 6 standard deviations of the invasion as % of the no-inhibitor control. The figure represents a summary of 2–4 experiments. Parasitemias were
determined by flow cytometry.
doi:10.1371/journal.ppat.1000968.g009
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ParCMean
ParC
, where ‘‘CorrParS’’ is
the corrected parasitemia of the sample, ‘‘ParS’’ is the uncorrected
parasitemia of the sample, ‘‘ParCMean’’ is the mean parasitemia
of all the control samples, and ‘‘ParC’’ is the uncorrected
parasitemia of the control for that sample.
CR1 Flow Cytometry
For detection of CR1, a 4% hematocrit cell suspension was
incubated with chicken anti-human CR1 Fab at 8 mg/ml for
30 min at RT and washed three times with RPMI 1640. The cell
sample was incubated with a 1:50 dilution of FITC-conjugated
goat anti-chicken IgG (Sigma-Aldrich) for 30 min at RT and
washed three times with RPMI and stored in 1% paraformalde-
hyde at 4uC until acquisition. During acquisition, erythrocytes
were gated on the basis of their forward and side scatter
characteristics and the median fluorescence intensity (MFI) was
measured using logarithmic amplification. To correct for day-to-
day variation when comparing the CR1 MFI among a series of
donors, the MFI was normalized to the mean of a control sample
that was included in all the assays using the formula
CorrMFIs~MFIs|
MFIcmean
MFIc
, where ‘‘CorrMFIs’’ and ‘‘MFIs’’
are the corrected and uncorrected sample MFI respectively,
‘‘MFIcmean’’ is the mean of all the MFI values of the standard
control, and ‘‘MFIc’’ is the mean of the control obtained in parallel
with the sample.
Detection of Parasitized Red Cells by Flow Cytometry
For detection of parasitized erythrocytes, cells were incubated in
1 mg/ml Hoechst 33342 (Invitrogen) prior to fixation. The
background staining of an uninfected red cell sample was always
subtracted. Mouse red cells were differentiated from human red
cells by use of PE-Cy5-labeled rat anti-mouse glycophorin (clone
TER-119, Becton-Dickinson, San Jose ´, CA, USA) at a dilution of
1:100. At least 10,000 erythrocytes were acquired for each sample.
Acquisition was done using a LSRII flow cytometer (Becton-
Dickinson) equipped with a UV laser and analysis was done using
Winlist v5.0 (Verity Software, Topsham, ME, USA). For
determination of % parasitemia (%P) of mouse red cells using
flow cytometry we used the following formula
%P~ %PEinf|100= %NEinfz%PEinf ðÞ ½ 
{ %PEui|100= %PEuiz%NEui ðÞ ½  ,
where %PEinf=%Hoechst positive erythrocytes in malaria
culture, %NEinf=%Hoechst negative erythrocytes in malaria
culture, %PEui=% Hoechst positive erythrocytes in uninfected
culture, and %NEui=% Negative erythrocytes in uninfected
culture. We always observed good correlation between flow
cytometry results and microscopy.
Polystyrene Microsphere Merozoite Binding Assay
Proteins were linked to 6 mm carboxylated polystyrene micro-
spheres using the PolyLink coupling kit (Polyciences Inc.,
Warrington, PA, USA). 10 mg of each protein was incubated
overnight at room temperature with 50 ml of a 2.6% suspension of
activated microspheres. The following day, the microspheres were
washed thrice with wash buffer by centrifugation at 1,0006g for
5 min. The microspheres were then resuspended in PBS
containing 100 mg/ml of BSA and incubated at room temperature
for 1 hr to block any remaining binding sites. Finally, the
microspheres were washed thrice again in PBS and stored at
4uC in 500 ml of PBS until used. Coating of microspheres with
proteins was confirmed by flow cytometry using polyclonal
antibodies against each protein (data not shown). 7G8 late
trophozoites and schizonts were purified by Percoll gradient
centrifugation [40]. Approximately 1610
6 infected red cells
(.80% parasitemia) were incubated with 8610
5 microspheres in
duplicate wells of a 96-well tissue culture plate containing 120 mlo f
complete medium and 25 mg/ml gentamicin. Chicken polyclonal
anti-CR1 (10 mlo f1mg/ml in PBS) or rabbit anti-BSA (Sigma-
Aldrich) (5 mlo f2 0mg/ml in PBS) was added to separate duplicate
wells. The plate was then incubated overnight at 37uC in a sealed
gas impermeable bag containing 5% CO2,5 %O 2, and 90% N2.
The following day, Giemsa-stained smears of each well were
prepared to confirm merozoite release and attachment. An equal
volume of PBS 2% paraformaldehyde containing 4 mg/ml
Hoechst 33342 (Invitrogen Corp.) was added to each well and
the plate was then stored at 4uC until acquisition took place.
Acquisition was carried out on an LSR II (Becton-Dickinson) using
the violet and 488 laser lines (Pennsylvania State University
College of Medicine Flow Core (www.hmc.psu.edu/core/flow/
overview.htm). The microspheres were gated based on their
forward and side scatter characteristics using logarithmic ampli-
fication. The % microspheres that showed Hoechst staining was
determined.
Immunofluorescent Microscopy of Polystyrene
Microspheres
Following overnight culture of malaria-infected red cells with
sCR1 or BSA-coated microspheres, a 50 ml aliquot of each culture
was centrifuged at 14,000 rpm for a few seconds and resuspended
in 1:100 chicken anti-CR1 in complete culture medium and
incubated at room temperature for two hours. The microspheres
were then washed twice with PBS and resuspended in 1:100
DyLight 488-labeled goat anti-chicken IgY (KPL, Inc., Gaithers-
burg, MD, USA) in PBS and incubated for 2 hours at room
temperature. After one wash in culture medium, the pellet was
resuspended in 2% paraformaldehyde with 4 mg/ml of Hoechst
33342 (Invitrogen) and incubated overnight at 4uC. The following
day, 5 ml of microsphere suspension was spotted onto a slide,
dried, and fixed with methanol. The microspheres were observed
under a Leica TCS SP2 AOBS confocal microscope using the
405 and 488 laser lines (www.hmc.psu.edu/core/microscopy/
confocal.htm).
Red Cell Immunofluorescent Microscopy
Schizont-infected erythrocytes were incubated with 10 mg/ml of
leupeptin (Sigma-Aldrich) for 8–12 hrs in complete medium at 37
uC, and then washed three times by centrifugation (4006g/4 min)
and resuspension in RPMI 1640 (Sigma-Aldrich) containing
25 mM Hepes and 0.2% NaHCO3. Fresh uninfected erythrocytes,
normal or neuraminidase-treated, were then added to the
parasitized erythrocytes to a final hematocrit of 2% and
parasitemia of 2% in complete medium and allowed to incubate
for 30–60 minutes until at least 50% of the parasite population
were membrane-enclosed merozoites. At this point, they were
diluted to 0.2% hematocrit and added to 14 mm collagen-coated
No.1 coverslips (MatTek Corporation, Ashland, MA, USA). After
incubating for 30 min at 37 uC to allow for attachment of the
erythrocytes to the collagen, the cells were fixed and prepared for
immunofluorescence using methods described by Tokumasu and
Dvorak [41]. Briefly, erythrocytes were cross-linked with 50 mM
dimethyl suberimidate dihydrochloride (DMS) (Thermo Fisher
Scientific) in a buffer containing 100 mM sodium borate buffer
(pH 9.5) and 1 mM MgCl2 for 1 hr at RT, followed by fixation
with 1% paraformaldehyde in PBS for 1 hr at RT. DMS and
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glycine in PBS, pH 7.4, for 1 hr at RT. After washing in PBS for
5 min, the erythrocytes were blocked with 3% BSA in PBS with
0.2% Tween 20 (blocking buffer) for 30 min at RT. Chicken
polyclonal anti-CR1 Fab (8 mg/ml), and rabbit polyclonal anti-
glycophorin A IgG (Accurate) (diluted 1:10 for neuraminidase-
treated cells and 1:50 for normal cells) were added in blocking
buffer for 1 hr at RT. Following three washes with PBS with 0.2%
Tween 20, the secondary antibodies goat anti-chicken IgG-Alexa
488, and goat anti-rabbit IgG-Alexa 555 (Santa Cruz) were diluted
1:50 in blocking buffer and incubated for 30 min at RT. Nuclei
were stained with Hoechst 33342 (2 mg/ml in PBS) (Invitrogen) for
15 min at RT. After a final wash in PBS with 0.2% Tween 20, the
coverslips were dried, mounted with Antifade (Biomeda), and
sealed to standard microscope slides. The fluorescence z-series
were collected on a LEICA DM RXA fluorescence microscope at
1006 under oil immersion. Prior to reconstruction, the images
were unsharp masked to remove the background and blurry parts
of the images and, subsequently, contrast enhanced using
TIFFany3 image processing software (Caffeinesoft, Inc., www.
caffeinesoft.com). This method provides highly satisfactory results
for small sharp features in the images as verified by comparison to
the original data sets. The 3D image reconstructions from 40-
plane image stacks were performed with BICViewer (Bioinstru-
mentation Center, USUHS, Bethesda, Maryland, USA).
Collection of Mouse Blood
Blood from human CR1 transgenic and wild-type mice in
C57BL/6 background was obtained by cardiac puncture following
deep anesthesia with inhaled isoflurane. Cardiac blood was
anticoagulated with citrate phosphate dextrose, shipped overnight
from the University of Massachusetts in Worcester, Massachusetts,
to the Walter Reed Army Institute of Research in Silver Spring,
Maryland, and used immediately upon arrival.
Ethics Statement
Collection of human blood samples for this study was conducted
according to the principles expressed in the Declaration of
Helsinki and under protocols approved by the Human Use
Research Committee of the Walter Reed Army Institute of
Research and/or the National Ethics Review Committee of the
Kenya Medical Research Institute. All patients provided written
informed consent for the collection of samples and subsequent
analysis. All animals were handled in strict accordance with good
animal practice as defined by the National Institutes of Health and
the Association for the Assessment and Accreditation of Labora-
tory Animal Care International (AAALAC) under a protocol
approved by the University of Massachusetts Medical School
Institutional Animal Care and Use Committee.
Statistical Analysis
Analysis was done using SPSS v11.5 (SPSS Inc., Chicago, IL,
USA). The general linear model, an analysis of variance
procedure, was used to test for equality of means across several
experimental groups taking into account matching across groups
by date of assay. If the overall F test was significant, Dunnett’s
pairwise multiple comparison t-test was used to compare each
experimental group mean to the control mean. Spearman rank
correlation was used to study the relationship between CR1 level
and invasion. The paired samples t-test or the non-parametric
Wilcoxon signed rank test, for small samples, was used for the
comparison of two paired samples. All tests were 2-sided with
a#0.05.
Supporting Information
Figure S1 Invasion inhibition by anti-CR1 and sCR1 remains
stable over a wide range of parasitemia. Enriched trophozoites/
schizonts were added to 2% hematocrit culture at varying
concentrations in duplicate wells of a 96-well plate while
maintaining the concentrations of inhibitors constant. Invasion
rate in the presence of inhibitors (shown on the y axis on the right)
was normalized to the no-inhibitor control invasion (shown on the
y axis on the left). Inhibition remains constant within the range of
starting parasitemias used in this study (up to 5%). Dots represent
means 6 standard deviations.
Found at: doi:10.1371/journal.ppat.1000968.s001 (0.05 MB
DOC)
Figure S2 Speckled pattern of CR1 in intact red cells is
eliminated by treatment with trypsin. (A) Cross-section of intact
red cells, (B) Cross-section of trypsinized red cells.
Found at: doi:10.1371/journal.ppat.1000968.s002 (0.28 MB
DOC)
Figure S3 More representative examples of interaction between
merozoites and CR1 on the surface of treated and untreated
(control) red cells. Merozoites (blue), CR1 (green), and glycophorin
A (red). DIC=Differential interference contrast.
Found at: doi:10.1371/journal.ppat.1000968.s003 (1.96 MB
DOC)
Table S1 Effect of Anti-CR1 and sCR1 on invasion of P.
falciparum wild strains.
Found at: doi:10.1371/journal.ppat.1000968.s004 (0.04 MB
DOC)
Video S1 Merozoite (blue) attached to CR1 (green) on the
surface of a red cell. This video corresponds to control in Figure 4,
main text.
Found at: doi:10.1371/journal.ppat.1000968.s005 (1.15 MB
MOV)
Video S2 Merozoite (blue)on the surface of a neuraminidase-
treated red cell with aggregation of CR1 (green) around the
merozoite. This video corresponds to neuraminidase-treated panel
in Figure 4 of the main text.
Found at: doi:10.1371/journal.ppat.1000968.s006 (1.30 MB
MOV)
Video S3 Merozoite (blue) attached to the surface of a
neuraminidase-treated red cell with aggregation of CR1 (green)-
between the merozoite and the red cell. This video corresponds to
supplementary Figure S1A.
Found at: doi:10.1371/journal.ppat.1000968.s007 (2.04 MB
MOV)
Video S4 Merozoite (blue) attached to the surface of a
neuraminidase-treated red cell with aggregation of CR1 (green)
around the merozoite. This video corresponds to supplementary
Figure S1B.
Found at: doi:10.1371/journal.ppat.1000968.s008 (0.63 MB
MOV)
Video S5 Merozoite (blue) on the surface of an untreated red cell
with increased CR1 (green) intensity at one end of the merozoite.
This video corresponds to supplementary Figure S1C.
Found at: doi:10.1371/journal.ppat.1000968.s009 (0.52 MB
MOV)
Video S6 Merozoite (blue) on the surface of an untreated red cell
with increased CR1 (green) intensity around the merozoite. This
video corresponds to supplementary Figure S1D.
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MOV)
Acknowledgments
We are grateful to Dr. J. David Haynes for support with malaria cultures
and for providing the 3D7 strain, and to Dr. Jacques Cohen of the
University of Reims, France, for the gift of monoclonal antibody J3B11.
We thank Dr. Fujuki Tokumatsu for sharing recent protocols for the
execution of immunofluorescent microscopy and Craig Morrissette for
advice on statistical analysis. Carolyn Fisher, Lucia Gerena, and Anna
Cerny are thanked for technical support.
The views of the authors do not purport to reflect the position of the
Department of the Army or the Department of Defense. The U.S.
Government has the right to retain a nonexclusive, royalty-free license in
and to any copyright covering this paper.
Author Contributions
Conceived and designed the experiments: CS GAA KMK GCT JAS.
Analyzed the data: JAS. Contributed reagents/materials/analysis tools:
JKM RWF. Wrote the paper: JAS. Performed all invasion assays with
microscopic readout, prepared cultures for immunofluorescent microscopy,
and carried out flow cytometry for CR1: CS. Edited the manuscript: CS
GAA KMK. Carried out all the invasion assays with flow cytometry
readout including experiments involving wild strains: GAA. Prepared cells
for and carried out immunofluorescent microscopy: KMK. Performed
immunofluorescent microscopy and processed data files: JC. Maintained
malaria cultures for experiments: JKM. Contributed human CR1
transgenic mouse strain: RWF. Posed the initial hypotheses, created an
outline of the design of the experiments, performed the microsphere
binding and immunofluorescent assays, and carried out the CR1
immunoprecipitation: JAS.
References
1. Miller LH, Haynes JD, McAuliffe FM, Shiroishi T, Durocher JR, et al. (1977)
Evidence for differences in erythrocyte surface receptors for the malarial
parasites, Plasmodium falciparum and Plasmodium knowlesi. J Exp Med 146:
277–281.
2. Deas JE, Lee LT (1981) Competitive inhibition by soluble erythrocyte
glycoproteins of penetration by Plasmodium falciparum. Am J Trop Med Hyg
30: 1164–1167.
3. Perkins M (1981) Inhibitory effects of erythrocyte membrane proteins on the in
vitro invasion of the human malarial parasite (Plasmodium falciparum) into its
host cell. J Cell Biol 90: 563–567.
4. Pasvol G, Jungery M, Weatherall DJ, Parsons SF, Anstee DJ, et al. (1982)
Glycophorin as a possible receptor for Plasmodium falciparum. Lancet 2:
947–950.
5. Maier AG, Duraisingh MT, Reeder JC, Patel SS, Kazura JW, et al. (2003)
Plasmodium falciparum erythrocyte invasion through glycophorin C and
selection for Gerbich negativity in human populations. Nat Med 9: 87–92.
6. Hadley TJ, Klotz FW, Pasvol G, Haynes JD, McGinniss MH, et al. (1987)
Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B
(MkMk). Strain differences indicate receptor heterogeneity and two pathways for
invasion. J Clin Invest 80: 1190–1193.
7. Holt EH, Nichols ME, Etzion Z, Perkins ME (1989) Erythrocyte invasion by two
Plasmodium falciparum isolates differing in sialic acid dependency in the
presence of glycophorin A antibodies. Am J Trop Med Hyg 40: 245–251.
8. Dolan SA, Miller LH, Wellems TE (1990) Evidence for a switching mechanism
in the invasion of erythrocytes by Plasmodium falciparum. J Clin Invest 86:
618–624.
9. Dolan SA, Proctor JL, Alling DW, Okubo Y, Wellems TE, et al. (1994)
Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of
human erythrocytes. Mol Biochem Parasitol 64: 55–63.
10. Mitchell GH, Hadley TJ, McGinniss MH, Klotz FW, Miller LH (1986) Invasion
of erythrocytes by Plasmodium falciparum malaria parasites: evidence for
receptor heterogeneity and two receptors. Blood 67: 1519–1521.
11. Baum J, Pinder M, Conway DJ (2003) Erythrocyte invasion phenotypes of
Plasmodium falciparum in The Gambia. Infect Immun 71: 1856–1863.
12. Deans AM, Nery S, Conway DJ, Kai O, Marsh K, et al. (2007) Invasion
Pathways and Malaria Severity in Kenyan Plasmodium falciparum Clinical
Isolates. Infect Immun 75: 3014–3020.
13. Sim RB (1985) Large-scale isolation of complement receptor type 1 (CR1) from
human erythrocytes. Proteolytic fragmentation studies. Biochem J 232: 883–889.
14. Da Silva RP, Hall BF, Joiner KA, Sacks DL (1989) CR1, the C3b receptor,
mediates binding of infective Leishmania major metacyclic promastigotes to
human macrophages. J Immunol 143: 617–622.
15. Zimmerli S, Edwards S, Ernst JD (1996) Selective receptor blockade during
phagocytosis does not alter the survival and growth of Mycobacterium
tuberculosis in human macrophages. Am J Respir Cell Mol Biol 15: 760–770.
16. Ahearn JM, Fearon DT (1989) Structure and function of the complement
receptors, CR1 (CD35) and CR2 (CD21). Adv Immunol 46: 183–219.
17. Meri S, Jarva H (1998) Complement regulation. Vox Sang 74 Suppl 2: 291–302.
18. Rowe JA, Moulds JM, Newbold CI, Miller LH (1997) P. falciparum rosetting
mediated by a parasite-variant erythrocyte membrane protein and complement-
receptor 1. Nature 388: 292–295.
19. Weisman HF, Bartow T, Leppo MK, Marsh HC, Jr., Carson GR, et al. (1990)
Soluble human complement receptor type 1: in vivo inhibitor of complement
suppressing post-ischemic myocardial inflammation and necrosis. Science 249:
146–151.
20. Nickells M, Hauhart R, Krych M, Subramanian VB, Geoghegan-Barek K, et al.
(1998) Mapping epitopes for 20 monoclonal antibodies to CR1. Clin Exp
Immunol 112: 27–33.
21. Rowe JA, Rogerson SJ, Raza A, Moulds JM, Kazatchkine MD, et al. (2000)
Mapping of the region of complement receptor (CR) 1 required for Plasmodium
falciparum rosetting and demonstration of the importance of CR1 in rosetting in
field isolates. J Immunol 165: 6341–6346.
22. Baruch DI, Gormely JA, Ma C, Howard RJ, Pasloske BL (1996) Plasmodium
falciparum erythrocyte membrane protein 1 is a parasitized erythrocyte receptor
for adherence to CD36, thrombospondin, and intercellular adhesion molecule 1.
Proc Natl Acad Sci U S A 93: 3497–3502.
23. Repik A, Pincus SE, Ghiran I, Nicholson-Weller A, Asher DR, et al. (2005) A
transgenic mouse model for studying the clearance of blood-borne pathogens via
human complement receptor 1 (CR1). Clin Exp Immunol 140: 230–240.
24. Kinoshita T, Takeda J, Hong K, Kozono H, Sakai H, et al. (1988) Monoclonal
antibodies to mouse complement receptor type 1 (CR1). Their use in a
distribution study showing that mouse erythrocytes and platelets are CR1-
negative. J Immunol 140: 3066–3072.
25. Klotz FW, Chulay JD, Daniel W, Miller LH (1987) Invasion of mouse
erythrocytes by the human malaria parasite, Plasmodium falciparum. J Exp Med
165: 1713–1718.
26. Terajima M, Matsui Y, Copeland NG, Gilbert DJ, Jenkins NA, et al. (1994)
Structural organization of the mouse glycophorin A gene. J Biochem (Tokyo)
116: 1105–1110.
27. Soubes SC, Reid ME, Kaneko O, Miller LH (1999) Search for the sialic acid-
independent receptor on red blood cells for invasion by Plasmodium falciparum.
Vox Sang 76: 107–114.
28. Pascual M, Duchosal MA, Steiger G, Giostra E, Pechere A, et al. (1993)
Circulating soluble CR1 (CD35). Serum levels in diseases and evidence for its
release by human leukocytes. J Immunol 151: 1702–1711.
29. Gardner B, Parsons SF, Merry AH, Anstee DJ (1989) Epitopes on
sialoglycoprotein alpha: evidence for heterogeneity in the molecule. Immunol-
ogy 68: 283–289.
30. Baum J, Maier AG, Good RT, Simpson KM, Cowman AF (2005) Invasion by P.
falciparum merozoites suggests a hierarchy of molecular interactions. PLoS
Pathog 1: e37.
31. Desimone TM, Jennings CV, Bei AK, Comeaux C, Coleman BI, et al. (2009)
Cooperativity between Plasmodium falciparum adhesive proteins for invasion
into erythrocytes. Mol Microbiol 72: 578–589.
32. Adams JH, Blair PL, Kaneko O, Peterson DS (2001) An expanding ebl family of
Plasmodium falciparum. Trends Parasitol 17: 297–299.
33. Gaur D, Mayer DC, Miller LH (2004) Parasite ligand-host receptor interactions
during invasion of erythrocytes by Plasmodium merozoites. Int J Parasitol 34:
1413–1429.
34. Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, et al. (2006) Upregulation of
expression of the reticulocyte homology gene 4 in the Plasmodium falciparum
clone Dd2 is associated with a switch in the erythrocyte invasion pathway. Mol
Biochem Parasitol 145: 205–215.
35. Stubbs J, Simpson KM, Triglia T, Plouffe D, Tonkin CJ, et al. (2005) Molecular
mechanism for switching of P. falciparum invasion pathways into human
erythrocytes. Science 309: 1384–1387.
36. Tham WH, Wilson DW, Reiling L, Chen L, Beeson JG, et al. (2009) Antibodies
to Reticulocyte Binding Like Homologue 4 Inhibit Invasion of P. falciparum into
Human Erythrocytes. Infect Immun.
37. Gaur D, Singh S, Singh S, Jiang L, Diouf A, et al. (2007) Recombinant
Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes
and blocks invasion. Proc Natl Acad Sci U S A 104: 17789–17794.
38. Persson KE, McCallum FJ, Reiling L, Lister NA, Stubbs J, et al. (2008)
Variation in use of erythrocyte invasion pathways by Plasmodium falciparum
mediates evasion of human inhibitory antibodies. J Clin Invest 118: 342–351.
39. Grech K, Chan BH, Anders RF, Read AF (2008) The impact of immunization
on competition within Plasmodium infections. Evolution 62: 2359–2371.
40. (2008) Methods in malaria research. Manassas: MR4/ATCC.
41. Tokumasu F, Dvorak J (2003) Development and application of quantum dots for
immunocytochemistry of human erythrocytes. J Microsc 211: 256–261.
CR1 Is a Malaria Sialic Acid-Independent Receptor
PLoS Pathogens | www.plospathogens.org 13 June 2010 | Volume 6 | Issue 6 | e1000968